Test designed to screen resistance to cancer drug
HONG KONG (Reuters) – Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the standard drug for treating leukemia or cancer of the blood cells.
Posts Tagged Health
Hire scheme aims to get Londoners on bikes
LONDON (Reuters) – A fleet of 6,000 bicycles for hire will hit the streets of central London on Friday when the city’s mayor Boris Johnson launches a scheme intended to fuel a cycling revolution in the congested capital.
2010 07 29
Court ruling could pave way for Gemzar generics
NEW YORK (Reuters) – A decision by a U.S. appeals court could pave the way for cheaper generic forms of Eli Lilly and Co’s Gemzar cancer drug to be launched in the United States beginning in mid-November.
FDA considering changes to risky drug safeguards
WASHINGTON (Reuters) – Safeguards to protect patients from risky drugs should have less paperwork and more consistency, drugmakers and pharmacy representatives said this week during a U.S. Food and Drug Administration meeting.
Rabbits grow their own joint replacements in study
WASHINGTON (Reuters) – Rabbits implanted with artificial bones re-grew their own joints, complete with cartilage, researchers reported on Thursday.
Bystander CPR — no breaths necessary, studies say
BOSTON (Reuters) – When someone collapses suddenly, mouth-to-mouth rescue breathing may not be necessary and could lower the chances of survival, researchers said in two studies on Wednesday that found chest compression alone is enough.
2010 07 28
U.N. assembly asserts water rights, some disagree
UNITED NATIONS (Reuters) – The U.N. General Assembly asserted a global right to water and sanitation in a resolution on Wednesday, but more than 40 countries abstained, saying no such right yet existed in international law.
Wireless sensor watches blood sugar for diabetics
WASHINGTON (Reuters) – Researchers have developed an implantable sensor that measures blood sugar continuously and transmits the information without wires — a milestone, they said, in diabetes treatment.
‘Excellence’ centers no better for bariatric surgery
NEW YORK (Reuters Health) – For weight-loss surgery, “Centers of Excellence” may not be any safer than their undistinguished peers, a study of 25 Michigan hospitals suggests.
Mental health experts ask: Will anyone be normal?
LONDON (Reuters) – An updated edition of a mental health bible for doctors may include diagnoses for “disorders” such as toddler tantrums and binge eating, experts say, and could mean that soon no-one will be classed as normal.
Hospital denies suspected killer got new liver
NEW YORK (Reuters Health) – The widely reported liver transplant at the New York-Presbyterian Hospital to alleged killer Johnny Concepcion never took place, a spokesperson told Reuters Health on Tuesday.
AstraZeneca bloodthinner goes before U.S. experts
ADELPHI, Maryland (Reuters) – AstraZeneca Plc’s experimental blood thinner goes before U.S. advisers on Wednesday, facing questions over why a trial of the potential blockbuster drug failed to cut heart attacks and deaths in North American patients.